Discover how quantum-resistant key management secures AI model deployments, protecting against quantum computing threats with advanced encryption and zero-trust strategies.
Italfarmaco S.p.A. and JCR Pharmaceuticals Co., Ltd. (TSE 4552; "JCR"), today announced an exclusive licensing agreement for the development and commercialisation of givinostat in Japan. Under the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback